Focusing on more selective MAGL inhibitors to be used for migraine pain treatment, URB602 [129] and JZL184 [130] are able to reduce trigeminal hyperalgesia in rat NTG models of migraine (Table 1) [131]. Here, MGLL is linked to migraine disorder.